Literature DB >> 33844936

Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis.

SeungHye Han1, Navdeep S Chandel1,2.   

Abstract

Metabolism is essential for a living organism to sustain life. It provides energy to a cell by breaking down compounds (catabolism) and supplies building blocks for the synthesis of macromolecules (anabolism). Signal transduction pathways tightly regulate mammalian cellular metabolism. Simultaneously, metabolism itself serves as a signaling pathway to control many cellular processes, such as proliferation, differentiation, cell death, gene expression, and adaptation to stress. Considerable progress in the metabolism field has come from understanding how cancer cells co-opt metabolic pathways for growth and survival. Recent data also show that several metabolic pathways may participate in the pathogenesis of lung diseases, some of which could be promising therapeutic targets. In this translational review, we will outline the basic metabolic principles learned from the cancer metabolism field as they apply to the pathogenesis of pulmonary arterial hypertension and fibrosis and will place an emphasis on therapeutic potential.

Entities:  

Keywords:  metabolism; metformin; pulmonary arterial hypertension; pulmonary fibrosis

Mesh:

Substances:

Year:  2021        PMID: 33844936      PMCID: PMC8399574          DOI: 10.1165/rcmb.2020-0550TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  80 in total

1.  A mitochondrial switch promotes tumor metastasis.

Authors:  Paolo E Porporato; Valéry L Payen; Jhudit Pérez-Escuredo; Christophe J De Saedeleer; Pierre Danhier; Tamara Copetti; Suveera Dhup; Morgane Tardy; Thibaut Vazeille; Caroline Bouzin; Olivier Feron; Carine Michiels; Bernard Gallez; Pierre Sonveaux
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

2.  PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.

Authors:  Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 3.  Mitochondria in vascular health and disease.

Authors:  Peter Dromparis; Evangelos D Michelakis
Journal:  Annu Rev Physiol       Date:  2012-11-16       Impact factor: 19.318

4.  Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Kazuya Tsubouchi; Jun Araya; Masahiro Yoshida; Taro Sakamoto; Tomoko Koumura; Shunsuke Minagawa; Hiromichi Hara; Yusuke Hosaka; Akihiro Ichikawa; Nayuta Saito; Tsukasa Kadota; Yusuke Kurita; Kenji Kobayashi; Saburo Ito; Yu Fujita; Hirofumi Utsumi; Mitsuo Hashimoto; Hiroshi Wakui; Takanori Numata; Yumi Kaneko; Shohei Mori; Hisatoshi Asano; Hideki Matsudaira; Takashi Ohtsuka; Katsutoshi Nakayama; Yoichi Nakanishi; Hirotaka Imai; Kazuyoshi Kuwano
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

5.  Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation.

Authors:  Karen Bernard; Naomi J Logsdon; Gloria A Benavides; Yan Sanders; Jianhua Zhang; Victor M Darley-Usmar; Victor J Thannickal
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

6.  Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.

Authors:  Evangelos D Michelakis; M Sean McMurtry; Xi-Chen Wu; Jason R B Dyck; Rohit Moudgil; Teresa A Hopkins; Gary D Lopaschuk; Lakshmi Puttagunta; Ross Waite; Stephen L Archer
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

7.  Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.

Authors:  Huijuan Xiao; Xiaoxi Huang; Shiyao Wang; Zheng Liu; Run Dong; Dingyun Song; Huaping Dai
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

8.  Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms.

Authors:  Yang Song; Yuanyuan Wu; Xiaofan Su; Yanting Zhu; Lu Liu; Yilin Pan; Bo Zhu; Lan Yang; Li Gao; Manxiang Li
Journal:  Pharmacol Res       Date:  2016-03-15       Impact factor: 7.658

9.  Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.

Authors:  Cui Zhai; Wenhua Shi; Wei Feng; Yanting Zhu; Jian Wang; Shaojun Li; Xin Yan; Qingting Wang; Qianqian Zhang; Limin Chai; Cong Li; Pengtao Liu; Manxiang Li
Journal:  Life Sci       Date:  2018-07-17       Impact factor: 5.037

10.  Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study.

Authors:  Yidan D Zhao; Li Yin; Stephen Archer; Catherine Lu; George Zhao; Yan Yao; Licun Wu; Michael Hsin; Thomas K Waddell; Shaf Keshavjee; John Granton; Marc de Perrot
Journal:  BMJ Open Respir Res       Date:  2017-06-05
View more
  1 in total

1.  Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.

Authors:  Takayuki Kobayashi; Jun-Dal Kim; Akira Naito; Asako Yanagisawa; Takayuki Jujo-Sanada; Yoshitoshi Kasuya; Yoshimi Nakagawa; Seiichiro Sakao; Koichiro Tatsumi; Takuji Suzuki
Journal:  Int J Mol Med       Date:  2022-03-22       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.